Clover Health Investments, Corp. (CLOV)
Clover Health Investments, Corp. (CLOV) Insider Trading
Directors, officers and holders of more than 10% of CLOV report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 220 transactions on file: 0 with code P, 36 with code S and 14 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Soares Karen | Chief Legal Officer | S Sale | 19,275 | $4.66 | $89,822 |
| Oct 19, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 4,066 | $4.41 | $17,931 |
| Oct 15, 2026 | Toy Andrew | Chief Executive Officer | S Sale | 62,176 | $4.68 | $290,984 |
| Oct 15, 2026 | Soares Karen | Chief Legal Officer | S Sale | 14,673 | $4.68 | $68,670 |
| Oct 15, 2026 | Wai Conrad | CEO, Counterpart Health | S Sale | 23,627 | $4.68 | $110,574 |
| Oct 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 18,273 | $4.68 | $85,518 |
| Oct 15, 2026 | THORNTON JOSEPH CLAY | Interim CFO | S Sale | 4,591 | $4.68 | $21,486 |
| Oct 7, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 2,006 | $4.63 | $9,288 |
| Oct 5, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 8,750 | $4.42 | $38,675 |
| Oct 1, 2026 | Toy Andrew | Chief Executive Officer | S Sale | 318,806 | $4.19 | $1,335,797 |
| Sep 30, 2026 | Miller Brian James | Director | A Award | 12,481 | Not measured | Not measured |
| Sep 30, 2026 | Torricelli Robert G | Director | A Award | 12,481 | Not measured | Not measured |
| Sep 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 1,921 | $4.56 | $8,760 |
| Sep 16, 2026 | OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | S Sale | 3,170 | $4.64 | $14,709 |
| Sep 15, 2026 | Wai Conrad | CEO, Counterpart Health | S Sale | 300,000 | $4.72 | $1,416,000 |
| Sep 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 9,273 | $4.78 | $44,325 |
| Sep 15, 2026 | Soares Karen | Chief Legal Officer | S Sale | 6,846 | $4.78 | $32,724 |
| Sep 14, 2026 | OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | S Sale | 20,000 | $5.16 | $103,200 |
| Aug 17, 2026 | THORNTON JOSEPH CLAY | Interim CFO | S Sale | 17,775 | $4.39 | $78,032 |
| Aug 12, 2026 | THORNTON JOSEPH CLAY | Interim CFO | A Award | 54,347 | Not measured | Not measured |
| Aug 12, 2026 | Soares Karen | Chief Legal Officer | A Award | 108,695 | Not measured | Not measured |
| Aug 10, 2026 | Toy Andrew | Chief Executive Officer | S Sale | 87,798 | $4.65 | $408,261 |
| Jul 20, 2026 | Soares Karen | Chief Legal Officer | S Sale | 51,700 | $4.51 | $233,167 |
| Jul 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 4,839 | $4.53 | $21,921 |
| Jul 15, 2026 | Wai Conrad | CEO, Counterpart Health | S Sale | 24,215 | $4.67 | $113,084 |
| Jul 15, 2026 | Soares Karen | Chief Legal Officer | S Sale | 10,519 | $4.67 | $49,124 |
| Jul 15, 2026 | Toy Andrew | Chief Executive Officer | S Sale | 62,711 | $4.67 | $292,860 |
| Jul 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 13,119 | $4.67 | $61,266 |
| Jul 15, 2026 | THORNTON JOSEPH CLAY | Interim CFO | S Sale | 4,630 | $4.67 | $21,622 |
| Jul 8, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 2,384 | $4.68 | $11,157 |
| Jul 6, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 6,229 | $5.26 | $32,765 |
| Jul 1, 2026 | Toy Andrew | Chief Executive Officer | S Sale | 313,476 | $5.32 | $1,667,692 |
| Jun 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 2,360 | $4.78 | $11,281 |
| Jun 16, 2026 | OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | S Sale | 12,102 | $4.86 | $58,816 |
| Jun 15, 2026 | Soares Karen | Chief Legal Officer | S Sale | 4,681 | $4.61 | $21,579 |
| Jun 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 6,350 | $4.61 | $29,274 |
| Jun 11, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S Sale | 7,289 | $4.91 | $35,789 |
| May 28, 2026 | Wai Conrad | CEO, Counterpart Health | S Sale | 220,426 | $3.99 | $879,500 |
| May 18, 2026 | Edwards Carladenise Armbrister | Director | S Sale | 67,160 | $3.42 | $229,687 |
| May 16, 2026 | THORNTON JOSEPH CLAY | Interim CFO | F Tax Payment | 16,942 | $3.47 | $58,789 |
| May 13, 2026 | Priest Brady Patrick | CEO of Clover Care Services | S Sale | 98,039 | $3.52 | $345,097 |
| May 8, 2026 | Toy Andrew | Chief Executive Officer | F Tax Payment | 85,704 | $2.82 | $241,685 |
| Apr 18, 2026 | Priest Brady Patrick | CEO of Clover Care Services | F Tax Payment | 36,113 | $2.19 | $79,087 |
| Apr 15, 2026 | THORNTON JOSEPH CLAY | Interim CFO | F Tax Payment | 4,158 | $2.04 | $8,482 |
| Apr 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | F Tax Payment | 12,712 | $2.04 | $25,932 |
| Apr 15, 2026 | Wai Conrad | CEO, Counterpart Health | F Tax Payment | 23,463 | $2.04 | $47,865 |
| Apr 15, 2026 | Priest Brady Patrick | CEO of Clover Care Services | F Tax Payment | 15,471 | $2.04 | $31,561 |
| Apr 15, 2026 | Soares Karen | Chief Legal Officer | F Tax Payment | 10,161 | $2.04 | $20,728 |
| Apr 15, 2026 | Toy Andrew | Chief Executive Officer | F Tax Payment | 60,765 | $2.04 | $123,961 |
| Apr 3, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | F Tax Payment | 6,197 | $1.72 | $10,659 |
The full Form 4 history is on the CLOV company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.